PHASE II TRIAL OF 2-N (2-DIETHYLAMINOETHYL) 9-HYDROXY ELLIPTICINIUM CHLORIDE (SR95156B, DATELLIPTIUM) IN ADVANCED MEASURABLE GASTRIC CARCINOMA

  • Roh Jae-Kyung (Div. of Med. Onc., Yonsei Cancer Res. Center, Yonsei University) ;
  • Choi Jin-Hyuk (Div. of Med. Onc., Yonsei Cancer Res. Center, Yonsei University) ;
  • Lee In-Sook (Div. of Med. Onc., Yonsei Cancer Res. Center, Yonsei University) ;
  • Mondesir Jean-Marc (Div. of Med. Onc., Yonsei Cancer Res. Center, Yonsei University) ;
  • Kim Byung-Soo (Div. of Med. Onc., Yonsei Cancer Res. Center, Yonsei University)
  • Published : 1992.11.01